Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TNGX
#1450
Tango Therapeutics, Inc. - Common Stock
24.1
7
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.51%
Monthly Change
+0.79%
6 month change
+10.62%
Year Change
+188.77%
Previous Close
23.8
1
Open
23.5
7
Low
23.3
4
High
24.4
7
Markets
US Stock Market
Healthcare
Biotechnology
TNGX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2020
Quarterly report, Q3 FY2020
2020.11.13
Tango Therapeutics, Inc. quarterly report, Q3 FY2020
10-Q
Current report, Q3 FY2020
2020.09.14
Tango Therapeutics, Inc. current report, Q3 FY2020
8-K
Current report, Q3 FY2020
2020.09.09
Tango Therapeutics, Inc. current report, Q3 FY2020
8-K
1
2
3
4
5
6
7
8
News
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report?
RVMD Secures FDA Win, Gets Nod for Rasonque in Pancreatic Cancer
Tango Therapeutics Stock: Promising Early Data, But A Long Road Ahead (NASDAQ:TNGX)
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer
How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48%
Tango Therapeutics Rides a New Precision Oncology Trend in 2026
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026?
TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts
Biotech Is The Rate Cut Trade In Disguise
Tango Therapeutics: Combo Data With Revolution's RAS Inhibitor Whets Risk Appetite (TNGX)